Skip to main content
SpringerLink
Log in

Introduction to Lung Disease

  • Chapter
  • First Online:
Targeting Epigenetics in Inflammatory Lung Diseases

  • 142 Accesses

Abstract

There has been a rise in the number of documented instances of lung illness in both children and adults around the globe. Both the morbidity and mortality rates associated with lung illness are from the unknown source. However, estimates from the GHO and other officialdoms imply that over 400 million people throughout the world are affected by asthma and COPD, most of them with very moderate symptoms. Non-infectious lung disease (LD) includes COPD, cystic fibrosis, asthma, lung cancer, and idiopathic pulmonary fibrosis (IPF), whereas infectious lung diseases include influenza, TB, and COPD. A combination of environmental circumstances, including an aging population and the absence of effective medications to the mild factor of LD, increased the chances of severe lung illnesses. With the widespread prevalence and devastating effects of lung diseases such as COPD, asthma, COVID-19, fibrosis, and flu-like symptoms, studies aimed at developing effective treatments and prevention measures are now being funded on a high-priority basis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
eBook
USD 139.00
Price excludes VAT (USA)
Hardcover Book
USD 179.99
Price excludes VAT (USA)

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Alharbi KS, Fuloria NK, Fuloria S, Rahman SB, Al-Malki WH, Javed Shaikh MA, et al. Nuclear factor-kappa B and its role in inflammatory lung disease. Chem Biol Interact. 2021;345:109568.

    Article  CAS  PubMed  Google Scholar 

  2. Chivima B. Lung cancer. Nurs Stand (Royal College of Nursing (Great Britain): 1987). 2015;29(22):61.

    Article  Google Scholar 

  3. Abolfathi H, Sheikhpour M, Shahraeini SS, Khatami S, Nojoumi SA. Studies in lung cancer cytokine proteomics: a review. Expert Rev Proteomics. 2021;18(1):49–64.

    Article  CAS  PubMed  Google Scholar 

  4. Abu Rous F, Singhi EK, Sridhar A, Faisal MS, Desai A. Lung cancer treatment advances in 2022. Cancer Investig. 2023;41(1):12–24.

    Article  Google Scholar 

  5. Amann A, Corradi M, Mazzone P, Mutti A. Lung cancer biomarkers in exhaled breath. Expert Rev Mol Diagn. 2011;11(2):207–17.

    Article  CAS  PubMed  Google Scholar 

  6. Avasarala SK, Rickman OB. Endobronchial therapies for diagnosis, staging, and treatment of lung cancer. Surg Clin North Am. 2022;102(3):393–412.

    Article  PubMed  Google Scholar 

  7. Bade BC, Dela Cruz CS. Lung cancer 2020: epidemiology, etiology, and prevention. Clin Chest Med. 2020;41(1):1–24.

    Article  PubMed  Google Scholar 

  8. Beattie EJ Jr. Lung cancer. CA Cancer J Clin. 1974;24(2):96–9.

    Article  PubMed  Google Scholar 

  9. Bitsko MJ, Everhart RS, Rubin BK. The adolescent with asthma. Paediatr Respir Rev. 2014;15(2):146–53.

    PubMed  Google Scholar 

  10. Barnthouse M, Jones BL. The impact of environmental chronic and toxic stress on asthma. Clin Rev Allergy Immunol. 2019;57(3):427–38.

    Article  PubMed  Google Scholar 

  11. Anwar ET, Gupta N, Porwal O, Sharma A, Malviya R, Singh A, et al. Skin diseases and their treatment strategies in Sub-Saharan African Regions. Infect Disord Drug Targets. 2022;22(2):e270921196808.

    Article  CAS  PubMed  Google Scholar 

  12. Agache I, Palmer E, Sanver D, Kirtland M, Shamji MH. Molecular allergology approach to allergic asthma. Mol Asp Med. 2022;85:101027.

    Article  CAS  Google Scholar 

  13. Boulet LP, Boulay M. Asthma-related comorbidities. Expert Rev Respir Med. 2011;5(3):377–93.

    Article  PubMed  Google Scholar 

  14. Dahiya R, Dahiya S, Fuloria NK, Kumar S, Mourya R, Chennupati SV, et al. Natural bioactive thiazole-based peptides from marine resources: structural and pharmacological aspects. Mar Drugs. 2020;18(6):329.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Busse WW, Melén E, Menzies-Gow AN. Holy Grail: the journey towards disease modification in asthma. Eur Respir Rev. 2022;31(163):210183.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Dahiya S, Dahiya R, Fuloria NK, Mourya R, Dahiya S, Fuloria S, et al. Natural bridged bicyclic peptide macrobiomolecules from celosia argentea and amanita phalloides. Mini Rev Med Chem. 2022;22(13):1772–88.

    Article  CAS  PubMed  Google Scholar 

  17. Chung KF. Clinical management of severe therapy-resistant asthma. Expert Rev Respir Med. 2017;11(5):395–402.

    CAS  PubMed  Google Scholar 

  18. Jones TL, Neville DM, Chauhan AJ. Diagnosis and treatment of severe asthma: a phenotype-based approach. Clin Med. 2018;18(Suppl 2):s36–40.

    Article  Google Scholar 

  19. Gans MD, Gavrilova T. Understanding the immunology of asthma: Pathophysiology, biomarkers, and treatments for asthma endotypes. Paediatr Respir Rev. 2020;36:118–27.

    PubMed  Google Scholar 

  20. Fuloria NK, Raheja RK, Shah KH, Oza MJ, Kulkarni YA, Subramaniyan V, et al. Biological activities of meroterpenoids isolated from different sources. Front Pharmacol. 2022;13:830103.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Kaur R, Chupp G. Phenotypes and endotypes of adult asthma: moving toward precision medicine. J Allergy Clin Immunol. 2019;144(1):1–12.

    Article  PubMed  Google Scholar 

  22. Kwah JH, Peters AT. Asthma in adults: principles of treatment. Allergy Asthma Proc. 2019;40(6):396–402.

    Article  CAS  PubMed  Google Scholar 

  23. Larenas-Linnemann D. [Asthma treatment]. Revista alergia Mexico (Tecamachalco, Puebla, Mexico: 1993). 2009;56 Suppl 1:S64–78.

    Google Scholar 

  24. Lemanske RF Jr, Busse WW. Asthma. JAMA. 1997;278(22):1855–73.

    Article  PubMed  Google Scholar 

  25. Miller RL, Grayson MH, Strothman K. Advances in asthma: new understandings of asthma’s natural history, risk factors, underlying mechanisms, and clinical management. J Allergy Clin Immunol. 2021;148(6):1430–41.

    Article  CAS  PubMed  Google Scholar 

  26. Mims JW. Asthma: definitions and pathophysiology. Int Forum Allergy Rhinol. 2015;5(Suppl 1):S2–6.

    PubMed  Google Scholar 

  27. Ntontsi P, Photiades A, Zervas E, Xanthou G, Samitas K. Genetics and epigenetics in asthma. Int J Mol Sci. 2021;22(5):2412.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Fuloria S, Mehta J, Talukdar MP, Sekar M, Gan SH, Subramaniyan V, et al. Synbiotic effects of fermented rice on human health and wellness: a natural beverage that boosts immunity. Front Microbiol. 2022;13:950913.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Fuloria S, Sekar M, Khattulanuar FS, Gan SH, Rani N, Ravi S, et al. Chemistry, biosynthesis and pharmacology of viniferin: potential resveratrol-derived molecules for new drug discovery, development and therapy. Molecules. 2022;27(16):5072.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Papadopoulos NG, Miligkos M, Xepapadaki P. A current perspective of allergic asthma: from mechanisms to management. Handb Exp Pharmacol. 2022;268:69–93.

    Article  CAS  PubMed  Google Scholar 

  31. Sockrider M, Fussner L. What is asthma? Am J Respir Crit Care Med. 2020;202(9):P25–6.

    Article  PubMed  Google Scholar 

  32. Wu TD, Brigham EP, McCormack MC. Asthma in the primary care setting. Med Clin North Am. 2019;103(3):435–52.

    Article  PubMed  PubMed Central  Google Scholar 

  33. COPD. Nurs Stand (Royal College of Nursing (Great Britain): 1987). 2015;29(42):16.

    Google Scholar 

  34. López-Campos JL, Tan W, Soriano JB. Global burden of COPD. Respirology. 2016;21(1):14–23.

    Article  PubMed  Google Scholar 

  35. Fuloria S, Subramaniyan V, Dahiya R, Dahiya S, Sudhakar K, Kumari U, et al. Mesenchymal stem cell-derived extracellular vesicles: regenerative potential and challenges. Biology. 2021;10(3):172.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Fuloria S, Yusri MAA, Sekar M, Gan SH, Rani N, Lum PT, et al. Genistein: a potential natural lead molecule for new drug design and development for treating memory impairment. Molecules. 2022;27(1):265.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Agustí A, Vogelmeier C, Faner R. COPD 2020: changes and challenges. Am J Physiol Lung Cell Mol Physiol. 2020;319(5):L879–l83.

    Article  PubMed  Google Scholar 

  38. Bagdonas E, Raudoniute J, Bruzauskaite I, Aldonyte R. Novel aspects of pathogenesis and regeneration mechanisms in COPD. Int J Chron Obstruct Pulmon Dis. 2015;10:995–1013.

    PubMed  PubMed Central  Google Scholar 

  39. Raherison C, Girodet PO. Epidemiology of COPD. Eur Respir Rev. 2009;18(114):213–21.

    Article  CAS  PubMed  Google Scholar 

  40. Barnes PJ. COPD 2020: new directions needed. Am J Physiol Lung Cell Mol Physiol. 2020;319(5):L884–l6.

    Article  CAS  PubMed  Google Scholar 

  41. Erhabor GE, Adeniyi B, Arawomo AO, Akinwalere O, Adetona G, Fagbohun FT, et al. Acute exacerbation of COPD: clinical perspectives and literature review. West Afr J Med. 2021;38(11):1129–42.

    Article  Google Scholar 

  42. Fischer BM, Voynow JA, Ghio AJ. COPD: balancing oxidants and antioxidants. Int J Chron Obstruct Pulmon Dis. 2015;10:261–76.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Guerreiro I, Soccal PM. [COPD and phenotypes]. Rev Med Suisse 2019;15(671):2082–6.

    Google Scholar 

  44. Tantucci C, Modina D. Lung function decline in COPD. Int J Chron Obstruct Pulmon Dis. 2012;7:95–9.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Gupta G, Almalki WH, Kazmi I, Fuloria NK, Fuloria S, Subramaniyan V, et al. Current update on the protective effect of naringin in inflammatory lung diseases. EXCLI J. 2022;21:573–9.

    PubMed  PubMed Central  Google Scholar 

  46. Hamid UZ, Sim MS, Guad RM, Subramaniyan V, Sekar M, Fuloria NK, et al. Molecular regulatory roles of long non-coding RNA HOTTIP: an overview in gastrointestinal cancers. Curr Mol Med. 2022;22(6):478–90.

    Article  CAS  PubMed  Google Scholar 

  47. Uwagboe I, Adcock IM, Lo Bello F, Caramori G, Mumby S. New drugs under development for COPD. Minerva Med. 2022;113(3):471–96.

    Article  PubMed  Google Scholar 

  48. Agusti A, Soriano JB. COPD as a systemic disease. COPD. 2008;5(2):133–8.

    Article  PubMed  Google Scholar 

  49. Aryal S, Diaz-Guzman E, Mannino DM. COPD and gender differences: an update. Transl Res. 2013;162(4):208–18.

    Article  PubMed  Google Scholar 

  50. Barnes PJ. Endo-phenotyping of COPD patients. Expert Rev Respir Med. 2021;15(1):27–37.

    Article  CAS  PubMed  Google Scholar 

  51. Huqh MZU, Abdullah JY, Wong LS, Jamayet NB, Alam MK, Rashid QF, et al. Clinical applications of artificial intelligence and machine learning in children with cleft lip and palate-a systematic review. Int J Environ Res Public Health. 2022;19(17):10860.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Jha S, Malviya R, Fuloria S, Sundram S, Subramaniyan V, Sekar M, et al. Characterization of microwave-controlled polyacrylamide graft copolymer of tamarind seed polysaccharide. Polymers. 2022;14(5):1037.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Kaur I, Behl T, Sehgal A, Singh S, Sharma N, Subramanian V, et al. A motley of possible therapies of the COVID-19: reminiscing the origin of the pandemic. Environ Sci Pollut Res Int. 2022;29(45):67685–703.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Kumar S, Behl T, Sehgal A, Chigurupati S, Singh S, Mani V, et al. Exploring the focal role of LRRK2 kinase in Parkinson’s disease. Environ Sci Pollut Res Int. 2022;29(22):32368–82.

    Article  CAS  PubMed  Google Scholar 

  55. Chakinala RC, Khatri A, Gupta K, Koike K, Epelbaum O. Sphingolipids in COPD. Eur Respir Rev. 2019;28(154):190047.

    PubMed  PubMed Central  Google Scholar 

  56. Duffy SP, Criner GJ. Chronic Obstructive Pulmonary Disease: Evaluation and Management. Med Clin North Am. 2019;103(3):453–61.

    Article  PubMed  Google Scholar 

  57. Gupta N, Agrawal S, Chakrabarti S, Ish P. COPD 2020 guidelines - what is new and why? Adv Respir Med. 2020;88(1):38–40.

    Article  PubMed  Google Scholar 

  58. Hanania NA, Sharma G, Sharafkhaneh A. COPD in the elderly patient. Semin Respir Crit Care Med. 2010;31(5):596–606.

    Article  PubMed  Google Scholar 

  59. Hattab Y, Alhassan S, Balaan M, Lega M, Singh AC. Chronic obstructive pulmonary disease. Crit Care Nurs Q. 2016;39(2):124–30.

    Article  PubMed  Google Scholar 

  60. Hering T. [COPD: Capture an exacerbation with just five questions]. MMW Fortschr Med 2022;164(10):61–3.

    Google Scholar 

  61. Labaki WW, Rosenberg SR. Chronic obstructive pulmonary disease. Ann Intern Med. 2020;173(3):Itc17–32.

    Article  PubMed  Google Scholar 

  62. Mortensen J, Berg RMG. Lung scintigraphy in COPD. Semin Nucl Med. 2019;49(1):16–21.

    Article  PubMed  Google Scholar 

  63. Lum PT, Sekar M, Gan SH, Jeyabalan S, Bonam SR, Rani N, et al. Therapeutic potential of mangiferin against kidney disorders and its mechanism of action: a review. Saudi J Biol Sci. 2022;29(3):1530–42.

    Article  CAS  PubMed  Google Scholar 

  64. Malviya R, Fuloria S, Verma S, Subramaniyan V, Sathasivam KV, Kumarasamy V, et al. Commercial utilities and future perspective of nanomedicines. PeerJ. 2021;9:e12392.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Petty TL. COPD in perspective. Chest. 2002;121(5 Suppl):116s–20s.

    Article  PubMed  Google Scholar 

  66. Rabe KF, Watz H. Chronic obstructive pulmonary disease. Lancet. 2017;389(10082):1931–40.

    Article  PubMed  Google Scholar 

  67. Tan WSD, Shen HM, Wong WSF. Dysregulated autophagy in COPD: a pathogenic process to be deciphered. Pharmacol Res. 2019;144:1–7.

    Article  CAS  PubMed  Google Scholar 

  68. Sethi T. Lung cancer.Introduction. Thorax. 2002;57(11):992–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Mustafa NH, Sekar M, Fuloria S, Begum MY, Gan SH, Rani N, et al. Chemistry, biosynthesis and pharmacology of sarsasapogenin: a potential natural steroid molecule for new drug design, development and therapy. Molecules. 2022;27(6):2032.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Nasir NN, Sekar M, Fuloria S, Gan SH, Rani N, Ravi S, et al. Kirenol: a potential natural lead molecule for a new drug design, development, and therapy for inflammation. Molecules. 2022;27(3):734.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Seale DD, Beaver BM. Pathophysiology of lung cancer. Nurs Clin North Am. 1992;27(3):603–13.

    Article  CAS  PubMed  Google Scholar 

  72. Rodescu D. Lung cancer. Med Clin North Am. 1977;61(6):1205–18.

    Article  CAS  PubMed  Google Scholar 

  73. Ruppert AM, Amrioui F, Fallet V. [Risk factors and prevention of lung cancer]. Rev Prat 2020;70(8):852–6.

    Google Scholar 

  74. Selvaraj LK, Jeyabalan S, Wong LS, Sekar M, Logeshwari B, Umamaheswari S, et al. Baicalein prevents stress-induced anxiety behaviors in zebrafish model. Front Pharmacol. 2022;13:990799.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Selvaraj S, Naing NN, Wan-Arfah N, Djearamane S, Wong LS, Subramaniyan V, et al. Epidemiological factors of periodontal disease among south indian adults. J Multidiscip Healthc. 2022;15:1547–57.

    Article  PubMed  PubMed Central  Google Scholar 

  76. McComb BL, Ko JP. Lung cancer imaging. J Thorac Imaging. 2011;26(2):83–4.

    Article  PubMed  Google Scholar 

  77. Novello S, Vavalà T. Lung cancer and women. Future Oncol. 2008;4(5):705–16.

    Article  PubMed  Google Scholar 

  78. Singh S, Hema, Sharma N, Sachdeva M, Behl T, Zahoor I, et al. Focusing the pivotal role of nanotechnology in Huntington’s disease: an insight into the recent advancements. Environ Sci Pollut Res Int. 2022;29(49):73809–27.

    Article  PubMed  Google Scholar 

  79. Subramaniyan V, Chakravarthi S, Jegasothy R, Seng WY, Fuloria NK, Fuloria S, et al. Alcohol-associated liver disease: a review on its pathophysiology, diagnosis and drug therapy. Toxicol Rep. 2021;8:376–85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  80. Chellappan DK, Chellian J, Leong JQ, Liaw YY, Gupta G, Dua K, et al. Biological and therapeutic potential of the edible brown marine seaweed Padina australis and their pharmacological mechanisms. J Trop Biol Conserv. 2020;17:251–71–71.

    Google Scholar 

  81. Krasna MJ. Lung cancer. Surg Oncol Clin N Am. 2011;20(4):xv–xvi.

    Article  PubMed  Google Scholar 

  82. Gudbjartsson T, Smáradottir A, Skúladóttir H, Grímsson HN, Hardardóttir H, Björnsson J, et al. [Lung cancer - review]. Laeknabladid 2008;94(4):297–311.

    Google Scholar 

  83. Giaccone G, Smit E. Lung cancer. Cancer Chemother Biol Response Modif. 2005;22:413–42.

    Article  CAS  PubMed  Google Scholar 

  84. Gilliland FD, Samet JM. Lung cancer. Cancer Surv. 1994;19–20:175–95.

    Google Scholar 

  85. Ernster VL. Female lung cancer. Annu Rev Public Health. 1996;17:97–114.

    Article  CAS  PubMed  Google Scholar 

  86. Vavalà T, Catino A, Pizzutilo P, Longo V, Galetta D. Gender Differences and Immunotherapy Outcome in Advanced Lung Cancer. Int J Mol Sci. 2021;22(21):11942.

    Article  PubMed  PubMed Central  Google Scholar 

  87. Stanton BF. Cystic fibrosis. Pediatr Clin N Am. 2016;63(4):xv.

    Article  Google Scholar 

  88. Savant AP, McColley SA. Cystic fibrosis year in review 2018, part 2. Pediatr Pulmonol. 2019;54(8):1129–40.

    Article  PubMed  Google Scholar 

  89. Savant AP, McColley SA. Cystic fibrosis year in review 2018, part 1. Pediatr Pulmonol. 2019;54(8):1117–28.

    Article  PubMed  Google Scholar 

  90. Savant AP, McColley SA. Cystic fibrosis year in review 2016. Pediatr Pulmonol. 2017;52(8):1092–102.

    Article  PubMed  Google Scholar 

  91. Rafeeq MM, Murad HAS. Cystic fibrosis: current therapeutic targets and future approaches. J Transl Med. 2017;15(1):84.

    Article  PubMed  PubMed Central  Google Scholar 

  92. Paranjape SM, Mogayzel PJ Jr. Cystic fibrosis. Pediatr Rev. 2014;35(5):194–205.

    Article  PubMed  Google Scholar 

  93. Radlović N. Cystic fibrosis. Srp Arh Celok Lek. 2012;140(3–4):244–9.

    Article  PubMed  Google Scholar 

  94. Leitch AE, Rodgers HC. Cystic fibrosis. J R Coll Physicians Edinb. 2013;43(2):144–50.

    Article  CAS  PubMed  Google Scholar 

  95. Ooi CY, Durie PR. Cystic fibrosis from the gastroenterologist’s perspective. Nat Rev Gastroenterol Hepatol. 2016;13(3):175–85.

    Article  CAS  PubMed  Google Scholar 

  96. Klimova B, Kuca K, Novotny M, Maresova P. Cystic fibrosis revisited - a review study. Med Chem. 2017;13(2):102–9.

    Article  CAS  PubMed  Google Scholar 

  97. De Boeck K. Cystic fibrosis in the year 2020: a disease with a new face. Acta Paediatr. 2020;109(5):893–9.

    Article  PubMed  Google Scholar 

  98. Endres TM, Konstan MW. What is cystic fibrosis? JAMA. 2022;327(2):191.

    Article  PubMed  Google Scholar 

  99. Hewlett JC, Kropski JA, Blackwell TS. Idiopathic pulmonary fibrosis: epithelial-mesenchymal interactions and emerging therapeutic targets. Matrix Biol. 2018;71–72:112–27.

    Google Scholar 

  100. King TE Jr, Pardo A, Selman M. Idiopathic pulmonary fibrosis. Lancet. 2011;378(9807):1949–61.

    Article  PubMed  Google Scholar 

  101. Kishaba T. Acute exacerbation of idiopathic pulmonary fibrosis. Medicina (Kaunas). 2019;55(3):70.

    Article  PubMed  PubMed Central  Google Scholar 

  102. Lederer DJ, Martinez FJ. Idiopathic pulmonary fibrosis. N Engl J Med. 2018;378(19):1811–23.

    Article  CAS  PubMed  Google Scholar 

  103. León-Román F, Valenzuela C, Molina-Molina M. Idiopathic pulmonary fibrosis. Med Clin. 2022;159(4):189–94.

    Article  Google Scholar 

  104. Martinez FJ, Collard HR, Pardo A, Raghu G, Richeldi L, Selman M, et al. Idiopathic pulmonary fibrosis. Nat Rev Dis Primers. 2017;3:17074.

    Article  PubMed  Google Scholar 

  105. Moss BJ, Ryter SW, Rosas IO. Pathogenic mechanisms underlying idiopathic pulmonary fibrosis. Annu Rev Pathol. 2022;17:515–46.

    Article  CAS  PubMed  Google Scholar 

  106. Cardona PJ. Pathogenesis of tuberculosis and other mycobacteriosis. Enferm Infecc Microbiol Clin (Engl Ed). 2018;36(1):38–46.

    Article  PubMed  Google Scholar 

  107. Casas I, Dominguez J, Rodríguez S, Matllo J, Altet N. [Guidelines for the prevention and control of tuberculosis in health care workers]. Med Clin. 2015;145(12):534.e1–13.

    Google Scholar 

  108. Jové N, Masdeu E, Brugueras S, Millet JP, Ospina JE, Orcau À, et al. Threats and interventions during the treatment of tuberculosis in an inner-city district. Arch Bronconeumol. 2021;57(5):330–7.

    Article  PubMed  Google Scholar 

  109. Ting BYS, Fuloria NK, Subrimanyan V, Bajaj S, Chinni SV, Reddy LV, et al. Biosynthesis and response of zinc oxide nanoparticles against periimplantitis triggering pathogens. Materials (Basel). 2022;15(9):3170.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  110. Tune BXJ, Sim MS, Poh CL, Guad RM, Woon CK, Hazarika I, et al. Matrix metalloproteinases in chemoresistance: regulatory roles, molecular interactions, and potential inhibitors. J Oncol. 2022;2022:3249766.

    Article  PubMed  PubMed Central  Google Scholar 

  111. Ketata W, Rekik WK, Ayadi H, Kammoun S. [Extrapulmonary tuberculosis]. Rev Pneumol Clin 2015;71(2–3):83–92.

    Google Scholar 

  112. Margarit A, Simó S, Rozas L, Deyà-Martínez À, Barrabeig I, Gené A, et al. [Adolescent tuberculosis; a challenge and opportunity to prevent community transmission]. An Pediatr (Barc). 2017;86(3):110–4.

    Google Scholar 

  113. Orcau À, Caylà JA, Martínez JA. Present epidemiology of tuberculosis. Prevention and control programs. Enferm Infecc Microbiol Clin. 2011;29(Suppl 1):2–7.

    Article  PubMed  Google Scholar 

  114. Yap KM, Sekar M, Wu YS, Gan SH, Rani N, Seow LJ, et al. Hesperidin and its aglycone hesperetin in breast cancer therapy: a review of recent developments and future prospects. Saudi J Biol Sci. 2021;28(12):6730–47.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  115. Zahoor I, Singh S, Behl T, Sharma N, Naved T, Subramaniyan V, et al. Emergence of microneedles as a potential therapeutics in diabetes mellitus. Environ Sci Pollut Res Int. 2022;29(3):3302–22.

    Article  PubMed  Google Scholar 

  116. Schito M, Migliori GB, Fletcher HA, McNerney R, Centis R, D’Ambrosio L, et al. Perspectives on advances in tuberculosis diagnostics, drugs, and vaccines. Clin Infect Dis. 2015;61Suppl 3(Suppl 3):S102–18.

    Article  PubMed  Google Scholar 

  117. Solsona Peiró J, de Souza Galvão ML, Altet Gómez MN. Inactive fibrotic lesions versus pulmonary tuberculosis with negative bacteriology. Arch Bronconeumol. 2014;50(11):484–9.

    Article  PubMed  Google Scholar 

  118. Hoa LNM, Sullivan SG, Mai LQ, Khvorov A, Phuong HVM, Hang NLK, et al. Influenza A(H1N1)pdm09 But Not A(H3N2) virus infection induces durable seroprotection: results from the ha nam cohort. J Infect Dis. 2022;226(1):59–69.

    Article  CAS  PubMed  Google Scholar 

  119. Zuraini NZA, Sekar M, Wu YS, Gan SH, Bonam SR, Mat Rani NNI, et al. Promising nutritional fruits against cardiovascular diseases: an overview of experimental evidence and understanding their mechanisms of action. Vasc Health Risk Manag. 2021;17:739–69.

    Article  PubMed  PubMed Central  Google Scholar 

  120. Itoh Y. Translational research on influenza virus infection using a nonhuman primate model. Pathol Int. 2016;66(3):132–41.

    Article  PubMed  Google Scholar 

  121. Mifsud EJ, Kuba M, Barr IG. Innate immune responses to influenza virus infections in the upper respiratory tract. Viruses. 2021;13(10):2090.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  122. Sura T, Gering V, Cammann C, Hammerschmidt S, Maaß S, Seifert U, et al. Streptococcus pneumoniae and influenza A virus co-infection induces altered polyubiquitination in A549 cells. Front Cell Infect Microbiol. 2022;12:817532.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  123. Pantin-Jackwood MJ, Swayne DE. Pathogenesis and pathobiology of avian influenza virus infection in birds. Rev Sci Tech. 2009;28(1):113–36.

    Article  CAS  PubMed  Google Scholar 

  124. Alsharif W, Qurashi A. Effectiveness of COVID-19 diagnosis and management tools: a review. Radiography (Lond). 2021;27(2):682–7.

    Article  CAS  PubMed  Google Scholar 

  125. Amit S, Beni SA, Biber A, Grinberg A, Leshem E, Regev-Yochay G. Postvaccination COVID-19 among Healthcare Workers, Israel. Emerg Infect Dis. 2021;27(4):1220–2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  126. Fernandes Q, Inchakalody VP, Merhi M, Mestiri S, Taib N, Moustafa Abo El-Ella D, et al. Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines. Ann Med. 2022;54(1):524–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  127. Habas K, Nganwuchu C, Shahzad F, Gopalan R, Haque M, Rahman S, et al. Resolution of coronavirus disease 2019 (COVID-19). Expert Rev Anti-Infect Ther. 2020;18(12):1201–11.

    Article  CAS  PubMed  Google Scholar 

  128. Majumder J, Minko T. Recent developments on therapeutic and diagnostic approaches for COVID-19. AAPS J. 2021;23(1):14.

    Article  CAS  PubMed  Google Scholar 

  129. Safiabadi Tali SH, LeBlanc JJ, Sadiq Z, Oyewunmi OD, Camargo C, Nikpour B, et al. Tools and techniques for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)/COVID-19 detection. Clin Microbiol Rev. 2021;34(3):e00228–0.

    Article  PubMed  PubMed Central  Google Scholar 

  130. Sidiq Z, Hanif M, Dwivedi KK, Chopra KK. Benefits and limitations of serological assays in COVID-19 infection. Indian J Tuberc. 2020;67(4s):S163–s6.

    Article  PubMed  PubMed Central  Google Scholar 

  131. Umakanthan S, Sahu P, Ranade AV, Bukelo MM, Rao JS, Abrahao-Machado LF, et al. Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19). Postgrad Med J. 2020;96(1142):753–8.

    CAS  PubMed  Google Scholar 

  132. Yüce M, Filiztekin E, Özkaya KG. COVID-19 diagnosis - a review of current methods. Biosens Bioelectron. 2021;172:112752.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Jeffrey Cheah School of Medicine and Health Sciences, MONASH University, Jalan Lagoon Selatan, Bandar Sunway, Selangor Darul Ehsan, Malaysia

    Vetriselvan Subramaniyan

  2. Faculty of Pharmacy, AIMST University, Bedong, Kedah, Malaysia

    Shivkanya Fuloria, Shalini Shanmugavelu, Kamini Vijeepallam & Neeraj Kumar Fuloria

  3. School of Pharmacy, MONASH University Malaysia, Subang Jaya, Selangor, Malaysia

    Mahendran Sekar

  4. Faculty of Medicine, AIMST University, Bedong, Kedah, Malaysia

    Usha Kumari & Kamal Narain

  5. College of Pharmacy, National University of Science and Technology, Muscat, Oman

    Dhanalekshmi Unnikrishnan Meenakshi

  6. Graduate School of Medicine, Perdana University, Kuala Lumpur, Malaysia

    Mohammad Nazmul Hasan Maziz

Authors
  1. Vetriselvan Subramaniyan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shivkanya Fuloria
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mahendran Sekar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shalini Shanmugavelu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kamini Vijeepallam
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Usha Kumari
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kamal Narain
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Dhanalekshmi Unnikrishnan Meenakshi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Mohammad Nazmul Hasan Maziz
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Neeraj Kumar Fuloria
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Neeraj Kumar Fuloria .

Editor information

Editors and Affiliations

  1. School of Pharmacy, Suresh Gyan University, Jaipur, Rajasthan, India

    Gaurav Gupta

  2. Department of Science, University of Technology Sydney, Ultimo, NSW, Australia

    Brian G. Oliver

  3. Discipline of Pharmacy, University of Technology Sydney, Schofields, NSW, Australia

    Kamal Dua

  4. Division of Pulmonary and Critical Care Medicine, Stanford Medicine, Stanford, CA, USA

    Md Khadem Ali

  5. School of Pharmacy, Gyan Vihar University, Jaipur, Rajasthan, India

    Piyush Dave

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Subramaniyan, V. et al. (2023). Introduction to Lung Disease. In: Gupta, G., Oliver, B.G., Dua, K., Ali, M.K., Dave, P. (eds) Targeting Epigenetics in Inflammatory Lung Diseases. Springer, Singapore. https://doi.org/10.1007/978-981-99-4780-5_1

Download citation

Publish with us

Policies and ethics

Search

Navigation